Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Elizabeth H Byrne, M.D.

Concepts (81)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Elizabeth Byrne's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Elizabeth Byrne has written about over time.
Contraceptive Agents, Female, 1 publications between 2015 and 2015, average publication date December 2015. Progestins, 1 publications between 2015 and 2015, average publication date December 2015. Antibodies, Monoclonal, 1 publications between 2017 and 2017, average publication date May 2017. Autoimmune Diseases, 1 publications between 2017 and 2017, average publication date May 2017. Vitiligo, 1 publications between 2017 and 2017, average publication date May 2017. HIV Infections, 2 publications between 2015 and 2021, average publication date November 2018. Lactobacillus, 2 publications between 2015 and 2024, average publication date November 2019. RNA, Ribosomal, 16S, 2 publications between 2015 and 2024, average publication date November 2019. Mumps virus, 1 publications between 2020 and 2020, average publication date February 2020. Vagina, 3 publications between 2015 and 2024, average publication date June 2020. Premature Birth, 1 publications between 2021 and 2021, average publication date September 2021. Inflammation, 2 publications between 2021 and 2024, average publication date January 2023. Postmenopause, 1 publications between 2024 and 2024, average publication date May 2024.

To see the data from this visualization as text, click here.
Byrne's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (81)
Explore
_
Co-Authors (34)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.